Physician profile
Arun Joseph
NPI 1316189905
$14,480.37
in general payments reported to CMS, 2019-2025
40 companies · $1,824 in 2025
The $1,824 reported for 2025 was more than what 76% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,633 · 2020: $1,454 · 2021: $2,691 · 2022: $1,390 · 2023: $1,106 · 2024: $2,383 · 2025: $1,824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,312.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,978.27 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Medtronic USA, INC. | $2,598.06 | 2019-2020 | |
| Boston Scientific Corporation | $2,419.49 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Abbott Laboratories | $1,442.33 | 2019-2024 | Proclaim |
| Nevro Corp. | $625.44 | 2022-2024 | Senza |
| Abbvie INC. | $421.59 | 2021-2024 | |
| Vertos Medical, INC. | $348.86 | 2019-2024 | Mild Device Kit |
| Biotronik Nro, INC. | $323.28 | 2024-2025 | Prospera |
| Stryker Corporation | $239.97 | 2019-2024 | Mild Device Kit |
| Si-Bone, INC. | $181.34 | 2019 | |
| Forte Bio-Pharma LLC | $180.54 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Stimwave Technologies Incorporated | $180.43 | 2019 | |
| Globus Medical, INC. | $150.94 | 2025 | Senza, Vyrsa V1 |
| Relievant Medsystems, INC. | $122.30 | 2021-2022 | |
| Bioventus LLC | $120.98 | 2019 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.